Laurie Glimcher, Dana-Farber president and CEO (Franck Fife/AFP via Getty Images)
Dana-Farber CEO Laurie Glimcher resigns from GSK board — is she the next NIH director nominee?
GSK announced this morning in a London Stock Exchange filing that Laurie Glimcher, president and CEO of the Dana-Farber Cancer Institute, has advised the company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.